Importantly, utilizing HCC cell‐derived LOs as N‐WASP inhibitor delivery vehicles drastically abolished the inductive effect of VAPA‐enriched LOs on bone‐metastatic niche formation and HCC bone metastasis. Here, WASL is linked to hepatocellular carcinoma.